Estrogen plus progesterone capsules help the SVM. REPLENISH study

Authors
Category Primary study
JournalRev. colomb. menopaus
Year 2018
The REPLENISH study, a 12-month, multicenter, randomized, double-blind, phase 3 placebo-controlled trial, evaluated the efficacy, endometrial safety and overall safety of a single 17-estradiol plus progesterone (E + P) capsule for moderate treatment to severe vasomotor symptoms (SVM).
Epistemonikos ID: ebd5a229828e27dc3cf5da5fedb0aa052ca2371d
First added on: Jan 18, 2025